Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR TEST SYSTEMS director Laura Oliphant reported multiple open-market sales of common stock. On January 22, 2026, she sold 3,100, 1,026, 180, 100, and 140 shares of AEHR common stock at prices ranging from $31.38 to $31.485 per share.
After these transactions, she beneficially owned 18,432 shares directly and 7,665 shares indirectly through a trust. The directly held amount includes shares subject to unvested restricted stock units.
A holder of common stock filed a notice of proposed sale under Rule 144, covering 4,546 shares to be sold through Fidelity Brokerage Services LLC on or about 01/22/2026 on the NASDAQ market. The filing lists an aggregate market value of 142,750.68 for these shares and notes that there are 30,627,342 shares of the same class outstanding.
The shares to be sold were acquired as restricted stock vesting compensation from the issuer in multiple tranches between 01/27/2024 and 01/11/2025, including vestings of 558, 557, 558, 1,158, 557, and 1,158 shares. The person on whose behalf the sale is being made represents that they are not aware of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.
Aehr Test Systems officer Alistair N. Sporck reported a tax-related share withholding on company stock. On 01/19/2026, 387 shares of common stock were withheld at a price of $28.81 per share to cover tax obligations upon the vesting of restricted stock units. The filing clarifies that this was not a sale by the reporting person, but a share withholding for taxes.
After this transaction, Sporck beneficially owned 28,305 shares of Aehr Test Systems common stock directly, which includes shares subject to unvested restricted stock units. In addition, the filing reports 5,214 shares held indirectly through a trust.
AEHR Test Systems executive Vernon Rogers reported a routine tax-related share withholding. On 01/14/2026, 464 shares of AEHR common stock were withheld at $25.97 per share to cover tax obligations that arose when restricted stock units vested. The company notes this withholding does not represent a sale by the executive.
After this transaction, Rogers beneficially owned 177,366 shares, which includes shares underlying unvested restricted stock units. The filing reflects the executive’s updated equity position rather than an open-market trade.
AEHR TEST SYSTEMS chief technology officer Donald P. Richmond II reported a routine tax-related share withholding. On 01/14/2026, 343 shares of common stock were withheld at a price of $25.97 per share to cover tax obligations triggered by the vesting of restricted stock units, and this was not an open-market sale. After this transaction, he beneficially owned 213,334 shares, which include shares subject to unvested restricted stock units, all held in direct ownership form.
AEHR Test Systems President and CEO Erickson Gayn reported a tax-related share withholding rather than an open-market sale. On January 14, 2026, 2,680 shares of common stock were withheld at $25.97 per share to cover tax obligations triggered by the vesting of restricted stock units and restricted shares, and the filing states this does not represent a sale by the reporting person. Following this transaction, Gayn directly beneficially owned 252,119 shares of common stock and indirectly beneficially owned 291,628 shares through a trust, with the indirect holdings reported as "By Trust."
Aehr Test Systems VP of Engineering filed an amended Form 4 to correct previously reported figures related to a tax withholding transaction on common stock dated 01/11/2026. The amendment clarifies that 486 shares were withheld to satisfy tax obligations at a price of $26.32 per share, rather than the 576 shares originally reported. It also updates the officer’s direct beneficial ownership after the transaction from the previously stated 213,587 shares to the correct total of 213,677 common shares.
AEHR TEST SYSTEMS President and CEO Erickson Gayn reported tax-related share withholding, not an open-market sale. On January 11, 2026, 3,531 shares of AEHR common stock were withheld at $26.32 per share to cover tax obligations triggered by the vesting of restricted stock units and restricted shares, as explained in the footnote.
After this transaction, Gayn beneficially owned 254,799 shares of common stock directly and 291,628 shares indirectly through a trust. The indirect amount includes shares subject to unvested restricted stock units and unvested restricted shares.
AEHR TEST SYSTEMS executive Vernon Rogers reported a routine tax-related share withholding tied to restricted stock units. On 01/11/2026, 576 shares of common stock were withheld at $26.32 per share to cover tax obligations when his restricted stock units vested, and this was not an open-market sale by Rogers. Following this transaction, he beneficially owned 177,830 shares of AEHR common stock, which the disclosure notes includes shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS CTO Donald P. Richmond II reported a routine share withholding transaction related to equity compensation. On 01/11/2026, 576 shares of common stock were withheld at $26.32 per share to cover tax obligations that arose when restricted stock units vested. The filing states this does not represent a sale by the reporting person, but an administrative tax withholding.
After this transaction, Richmond beneficially owned 213,587 shares of AEHR Test Systems common stock, and this amount includes shares subject to unvested restricted stock units. The filing confirms that these holdings are reported as directly owned.